Toreforant

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Toreforant (JNJ-38518168) is an orally-dosed selective antagonist of the histamine H 4 receptor that has been studied for various health conditions. It is the successor of a number of H 4 -selective compounds developed by Johnson & Johnson. Phase IIa clinical trials completed as recently as November 2018 continue to suggest that toreforant is safe. As of the end of 2020, there is no regulator-approved H 4 antagonist. In U.S. Phase II clinical trials, toreforant, by itself, did not show efficacy against eosinophilic asthma. The drug did show at least partial efficacy against rheumatoid arthritis in patients who were nonresponsive to methotrexate. As the H 4 receptor is widely implicated in the regulation of inflammatory states, the potential uses for an H 4 antagonist remain significant.

Toreforant (JNJ-38518168) is an orally-dosed selective antagonist of the histamine H 4 receptor that has been studied for various health conditions. It is the successor of a number of H 4 -selective compounds developed by Johnson & Johnson. Phase IIa clinical trials completed as recently as November 2018 continue to suggest that toreforant is safe. As of the end of 2020, there is no regulator-approved H 4 antagonist. In U.S. Phase II clinical trials, toreforant, by itself, did not show efficacy against eosinophilic asthma. The drug did show at least partial efficacy against rheumatoid arthritis in patients who were nonresponsive to methotrexate. As the H 4 receptor is widely implicated in the regulation of inflammatory states, the potential uses for an H 4 antagonist remain significant.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1358133015 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.